JIE XU: Open Payments
NPI 1225518228 · CARMEL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$524 in 28 payments from 12 companies in 2025. Trend: 2023 $623 · 2024 $386 · 2025 $524
Food & beverage: $524
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $158 |
| Avadel CNS Pharmaceuticals, LLC | 4 | $92 |
| Axsome Therapeutics, Inc. | 3 | $59 |
| SK Life Science, Inc. | 2 | $39 |
| Neurocrine BioSciences, Inc. | 1 | $33 |
| Biogen, Inc. | 1 | $29 |
| EMD Serono, Inc. | 1 | $24 |
| Tonix Medicines, Inc. | 1 | $23 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $22 |
| UCB, Inc. | 1 | $20 |
Products named: QULIPTA, LUMRYZ, INGREZZA, AVONEX, Auvelity, TONMYA, JOURNAVX, Zilbrysq.
Industry payments across IN — which companies pay providers there.
